Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Soiffer Robert J.; Kim Haesook T.; McGuirk Joseph; Horwitz Mitchell E.; Johnston Laura; Patnaik Mrinal M.; Rybka Witold; Artz Andrew; Porter David L.; Shea Thomas C.; Boyer Michael W.; Maziarz Richard T.; Shaughnessy Paul J.; Gergis Usama; Safah Hana; Reshef Ran; DiPersio John F.; Stiff Patrick J.; Vusirikala Madhuri; Szer Jeff; Holter Jennifer; Levine James D.; Martin Paul J.; Pidala Joseph A.; Lewis Ian D.; Ho Vincent T.; Alyea Edwin P.; Ritz Jerome; Glavin Frank; Westervelt Peter; Jagasia Madan H.; Chen Yi-Bin

首页> 外文期刊>Journal of Clinical Oncology >Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

【24h】

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

机译：抗T淋巴细胞球蛋白的前瞻性，随机双盲，第III期临床试验，以评估HLA匹配无关的无关的肌大学造血细胞移植患者对慢性接枝的影响对慢性移植物与宿主病生存

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2017年第36期|共15页
作者
Soiffer Robert J.; Kim Haesook T.; McGuirk Joseph; Horwitz Mitchell E.; Johnston Laura; Patnaik Mrinal M.; Rybka Witold; Artz Andrew; Porter David L.; Shea Thomas C.; Boyer Michael W.; Maziarz Richard T.; Shaughnessy Paul J.; Gergis Usama; Safah Hana; Reshef Ran; DiPersio John F.; Stiff Patrick J.; Vusirikala Madhuri; Szer Jeff; Holter Jennifer; Levine James D.; Martin Paul J.; Pidala Joseph A.; Lewis Ian D.; Ho Vincent T.; Alyea Edwin P.; Ritz Jerome; Glavin Frank; Westervelt Peter; Jagasia Madan H.; Chen Yi-Bin;
展开▼
作者单位

Dana Farber Canc Inst DA 2-032 450 Brookline Ave Boston MA 02215 USA;

Dana Farber Canc Inst DA 2-032 450 Brookline Ave Boston MA 02215 USA;

Univ Kansas Med Ctr Kansas City KS 66103 USA;

Duke Univ Med Ctr Durham NC 27706 USA;

Stanford Univ Stanford CA 94305 USA;

Mayo Clin Rochester MN USA;

Penn State Coll Med Hershey PA USA;

Univ Chicago Chicago IL 60637 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Univ N Carolina Sch Med Chapel Hill NC USA;

Univ Utah Salt Lake City UT USA;

Oregon Hlth &

Sci Univ Portland OR 97201 USA;

Texas Transplant Inst San Antonio TX USA;

Weill Cornell Med Coll New York NY USA;

Tulane Univ New Orleans LA 70118 USA;

Columbia Univ Med Ctr New York NY USA;

Washington Univ Sch Med St Louis MO USA;

Loyola Univ Med Ctr 2160 S 1st Ave Maywood IL 60153 USA;

Univ Texas Southwestern Med Ctr Dallas Dallas TX 75390 USA;

Royal Melbourne Hosp Parkville Vic Australia;

Univ Oklahoma Hlth Sci Ctr Oklahoma City OK USA;

Beth Israel Deaconess Med Ctr Boston MA 02215 USA;

Fred Hutchinson Canc Res Ctr 1124 Columbia St Seattle WA 98104 USA;

H Lee Moffitt Canc Ctr &

Res Inst Tampa FL USA;

Royal Adelaide Hosp Adelaide SA Australia;

Dana Farber Canc Inst DA 2-032 450 Brookline Ave Boston MA 02215 USA;

Dana Farber Canc Inst DA 2-032 450 Brookline Ave Boston MA 02215 USA;

Dana Farber Canc Inst DA 2-032 450 Brookline Ave Boston MA 02215 USA;

Neovii Biotech Lexington MA USA;

Washington Univ Sch Med St Louis MO USA;

Vanderbilt Univ Med Ctr Nashville TN USA;

Massachusetts Gen Hosp Boston MA 02114 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation [J] . Soiffer Robert J., Kim Haesook T., McGuirk Joseph, Journal of Clinical Oncology . 2017,第36期

机译：抗T淋巴细胞球蛋白的前瞻性，随机双盲，第III期临床试验，以评估HLA匹配无关的无关的肌大学造血细胞移植患者对慢性接枝的影响对慢性移植物与宿主病生存
2. Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation [J] . M. M. Schubert, F. P. Eduardo, K. A. Guthrie, Supportive Care in Cancer . 2007,第11期

机译：第20届国际MASCC / ISOO周年研讨会摘要：一项III期随机双盲安慰剂对照临床试验，旨在确定低水平激光疗法对造血细胞移植患者口腔粘膜炎的预防作用
3. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation [J] . Mark M. Schubert, Fernanda P. Eduardo, Katherine A. Guthrie, Supportive Care in Cancer . 2007,第10期

机译：一项III期随机双盲安慰剂对照临床试验，旨在确定低水平激光疗法对造血细胞移植患者口腔粘膜炎的预防作用
4. A clinical trial of prophylactic antifungal therapy in patients undergoing hematopoietic stem cell transplantation [C] . Zhou Qi, Lou Fangding, Zhang Bolong Proceedings of the Fourth China-Jpan international congress of mycology . 1998

机译：造血干细胞移植患者预防性抗真菌治疗的临床试验
5. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
6. Impact of chronic graft-versus-host disease on late relapse and survival on 7489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia [O] . Michael Boyiadzis, Mukta Arora, John P. Klein, -1

机译：慢性异体造血细胞移植治疗白血病后慢性移植物抗宿主病对7489例患者晚期复发和存活的影响
7. Impact of Anti- T Lymphocyte Globulin (ATLG) on Immune Reconstitution in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT): Results From a Prospective Randomized Double Blind Phase 3 Clinical Trial [O] . Robert J. Soiffer, Haesook T. Kim, Yi-Bin Chen, 2017

机译：抗T淋巴细胞球蛋白（ATLG）对HLA匹配不相关的肌催化细胞移植（HCT）患者免疫重建的影响：前瞻性随机双盲期3临床试验的结果

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

摘要

著录项

相似文献

相关主题

期刊订阅